000			01926 a2200481 4500
005			20250517061510.0
264		0	_c20160906
008			201609s 0 0 eng d
022			_a1573-7217
024	7		_a10.1007/s10549-015-3624-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aGöbel, Andy
245	0	0	_aPotentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins. _h[electronic resource]
260			_bBreast cancer research and treatment _cDec 2015
300			_a623-31 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aAtorvastatin _xadministration & dosage
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor _xdrug effects
650	0	4	_aDiphosphonates _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aIntercellular Signaling Peptides and Proteins _xgenetics
650	0	4	_aMevalonic Acid _xantagonists & inhibitors
650	0	4	_aMice, Nude
650	0	4	_aOsteoblasts _xdrug effects
650	0	4	_aRosuvastatin Calcium _xadministration & dosage
650	0	4	_aSimvastatin _xadministration & dosage
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aZoledronic Acid
700	1		_aBrowne, Andrew J
700	1		_aThiele, Stefanie
700	1		_aRauner, Martina
700	1		_aHofbauer, Lorenz C
700	1		_aRachner, Tilman D
773	0		_tBreast cancer research and treatment _gvol. 154 _gno. 3 _gp. 623-31
856	4	0	_uhttps://doi.org/10.1007/s10549-015-3624-8 _zAvailable from publisher's website
999			_c25401056 _d25401056